Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-16-059376
Filing Date
2016-03-29
Accepted
2016-03-29 18:16:24
Documents
1
Period of Report
2016-03-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3287
  Complete submission text file 0001140361-16-059376.txt   4659
Mailing Address C/O INVIVO THERAPEUTICS HOLDING CORP. ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address
Wirth Edward (Reporting) CIK: 0001532558 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36646 | Film No.: 161536579

Mailing Address 6300 DUMBARTON CIRCLE FREMONT CA 94555
Business Address 6300 DUMBARTON CIRCLE FREMONT CA 94555 510-456-3805
Asterias Biotherapeutics, Inc. (Issuer) CIK: 0001572552 (see all company filings)

EIN.: 461047971 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)